Jeff Huber is the Managing Partner at Triatomic Capital, and the Founding CEO of GRAIL. GRAIL's mission is to detect cancer early when it can be cured.
Prior to GRAIL, Jeff was a SVP at Google where he co-founded Google's life sciences efforts in Google[x] (2013-2016), and led development and scaling for Google Maps (2011-2013), Google Apps (2005-2010), and Google Ads (2003-2011). During his tenure as an executive at Google, Jeff oversaw 50x growth in revenues (from $1 billion to >$50 billion) and organization (1,000 to >50,000 employees) and managed a $5 billion P&L and large distributed teams (5,000+ direct-line employees).
Jeff holds a bachelor's degree in computer engineering from the University of Illinois and a master's degree in business from Harvard University and was a Visiting Scholar in Stanford University's Department of BioEngineering.
Jeff is a board member of Mammoth Biosciences, Electronic Arts (EA), Upstart (UPST), Openwater, Genalyte, Zapata Computing, and the Parker Institute for Cancer Immunotherapy (PICI), and is a former board member of GRAIL (acquired for $10.1B), Aldevron (acquired for $9.6B), Ancestry.com (acquired for $4.7B), Weta Digital (tech assets acquired for $1.625B), and Illumina.
Jeff is an advisory board member for Stanford's Precision Health and Integrated Diagnostics (PHIND) Center, Duke University's Research Translation & Commercialization (RTC) Council, and sponsors the 'Huber-Vossough Chancellor’s Chair' in Computational Biomedicine at UC Berkeley.